Horse /

Breed profile · FDA CVM July 2026 extract

Belgian Draft, also called Brabant or Brabants trekpaard adverse-event record

Adverse-event filings for Belgian Draft, also called Brabant or Brabants trekpaard (Horse) in the FDA Center for Veterinary Medicine openFDA extract. Browse horse breeds, reactions, and outcomes below.

#289 of 510
by report volume (all breeds)
41
FDA CVM reports on file
12.2%
death-coded share of reports
7
Lack of efficacy - NOS - top reaction

How the 41 reports break down

By recorded gender -- every report on file for Belgian Draft, also called Brabant or Brabants trekpaard, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 3 2.25 1.5 0.75 0 2018 2019 2020 2021 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Belgian Draft, also called Brabant or Brabants trekpaard drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Belgian Draft, also called Brabant or Brabants trekpaard ranks #289 of 510 by total reports (41). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#289
This breed, reports of 510

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Belgian Draft, also called Brabant or Brabants trekpaard has 41 reports now versus 40 in that prior snapshot: 1 more (2.5%).

Report change
+1
Death-coded reports
+0
Death-coded share
−0.3 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Belgian Draft, also called Brabant or Brabants trekpaard changes

Total Reports

41

Below-median volume

Deaths Reported

5

of 41 reports

Death-coded share of reports

12.2%

12.2% death-coded

Avg Age at Report

13.6 yr

332.6 kg avg weight

Death-Coded Outcome Share

Belgian Draft, also called Brabant or Brabants trekpaard death-coded reports 12.2%
Cross-breed median

12.2% of 41 belgian draft, also called brabant or brabants trekpaard reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 332.6 kg (733.4 lbs)

Top Reported Reactions

Lack of efficacy - NOS 7
Swollen mouth 4
Abdominal pain 3
Anorexia 3
Hypersalivation 2

Most Referenced Drugs

Pergolide Mesylate 7
Firocoxib 5
Omeprazole 5
Ivermectin(1.55%)/Praziquantel(7.75%) Paste 4
Moxidectin 3

Outcome Breakdown

Outcome Unknown
17 (43.6%)
Recovered/Normal
11 (28.2%)
Ongoing
6 (15.4%)
Died
4 (10.3%)
Euthanized
1 (2.6%)

Gender Distribution

Male 22 (53.7%)
Female 15 (36.6%)
Unknown 2 (4.9%)
Mixed 2 (4.9%)

Reports by Year

Year Reports Trend
2010 1
2012 2
2013 5
2014 3
2015 4
2016 7
2017 3
2018 2
2019 3
2020 2
2021 2
2023 2
2024 2
2025 2
2026 1

Belgian Draft, also called Brabant or Brabants trekpaard: high death-coded share in the FDA CVM extract

Signature read: Belgian Draft, also called Brabant or Brabants trekpaard's 12.2% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Belgian Draft, also called Brabant or Brabants trekpaard sits at #289 of 510 by report volume among all breeds and #26 of 55 among horse breeds, with 41 reports and 5 (12.2%) death-coded. Mean age at report: 13.6 years, average weight 332.6 kg (733.4 lbs).

Top reported signs: Lack of efficacy - NOS (7), Swollen mouth (4), Abdominal pain (3). Most-referenced drug: Pergolide Mesylate (7 reports), followed by Firocoxib (5) and Omeprazole (5).

Outcome coding on 39 status-recorded reports is dominated by Outcome Unknown (43.6%). Annual submissions ranged 1-2,026 across 15 years on file.

Horse Breeds With a Similar Report Volume

Showing 6 of 54 horse breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Belgian Draft, also called Brabant or Brabants trekpaard, both outside the Horse family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar average weight

Nearest other-species breeds by reported average weight (332.6 kg here).

What to do with this horse

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Belgian Draft, also called Brabant or Brabants trekpaard?
There are 41 adverse event reports involving Belgian Draft, also called Brabant or Brabants trekpaard in the FDA database, of which 5 were death-coded (12.2% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Belgian Draft, also called Brabant or Brabants trekpaard ranks #289 of 510 by report volume among all breeds PlainBreed indexes (#26 of 55 among horse breeds).
Where does Belgian Draft, also called Brabant or Brabants trekpaard sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Belgian Draft, also called Brabant or Brabants trekpaard is #289 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Horse, it is #26 of 55. It has fewer than 50 reports, so it is outside the death-rate ranking cohort (≥50 reports). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Belgian Draft, also called Brabant or Brabants trekpaard?
The most commonly reported adverse reactions for Belgian Draft, also called Brabant or Brabants trekpaard are Lack of efficacy - NOS (7 reports), Swollen mouth (4 reports), Abdominal pain (3 reports), Anorexia (3 reports), Hypersalivation (2 reports).
What drugs are most frequently associated with Belgian Draft, also called Brabant or Brabants trekpaard adverse events?
The drugs most frequently referenced in Belgian Draft, also called Brabant or Brabants trekpaard adverse event reports are Pergolide Mesylate (7 reports), Firocoxib (5 reports), Omeprazole (5 reports), Ivermectin(1.55%)/Praziquantel(7.75%) Paste (4 reports), Moxidectin (3 reports).
What is the average age of Belgian Draft, also called Brabant or Brabants trekpaard in adverse event reports?
The average age of Belgian Draft, also called Brabant or Brabants trekpaard at the time of adverse event reports is 13.6 years, with an average weight of 332.6 kg (733.4 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Belgian Draft, also called Brabant or Brabants trekpaard (Horse), extract as of July 2026 extract. 41 reports · 5 death-coded (12.2% of reports, not a mortality rate) · #289 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →